about
Pregnancy and vascular liver diseaseWilson's disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamineManagement of the critically ill patient with cirrhosis: A multidisciplinary perspective.Interplay of Inflammation and Endothelial Dysfunction in Bone Marrow Transplantation: Focus on Hepatic Veno-Occlusive Disease.Determination of the most influential sources of variability in tacrolimus trough blood concentrations in adult liver transplant recipients: a bottom-up approachEstimation of the prevalence of intraductal papillary mucinous neoplasm of the pancreas in the French population through patients waiting for liver transplantationDonor safety in living related liver transplantation: underestimation of the risks for deep vein thrombosis and pulmonary embolism.Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.Liver autophagy in anorexia nervosa and acute liver injuryClinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis.Liver transplantation for hepatocellular carcinoma: role of biopsy.Plasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver-transplant waiting list.Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulationMultifactorial aetiology of hepatic infarction: a case report with literature review.Extracorporeal membrane oxygenation as a bridge to liver transplantation for acute respiratory distress syndrome-induced life-threatening hypoxaemia aggravated by hepatopulmonary syndrome.Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD.Bevacizumab to Treat Cholangiopathy in Hereditary Hemorrhagic Telangiectasia: Be Cautious: A Case ReportWilson's disease: an old disease keeps its old secrets.Prevalence, molecular epidemiology, and clinical significance of heterogeneous glycopeptide-intermediate Staphylococcus aureus in liver transplant recipients.Assessment of prognosis of cirrhosis.The use of a liver with a gunshot injury as a donor for auxiliary liver transplantation: Case reportEntecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B.Report of the Paris consensus meeting on expanded criteria donors in liver transplantation.Severe sepsis in cirrhosis.The evaluation of renal function and disease in patients with cirrhosis.Autophagy in liver diseases.Is tumor biopsy necessary?Management of critically-ill cirrhotic patients.Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites.Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial.Acute Kidney Injury in Cirrhosis.Pathogenesis of Hepatorenal Syndrome: Implications for Therapy.The future of liver transplantation for viral hepatitis.Use of everolimus in liver transplantation: The French experience.Kidney biomarkers in cirrhosis.Liver sinusoidal endothelial cells: Physiology and role in liver diseases.Long-term outcome in liver transplantation candidates with portopulmonary hypertension.Liver Involvement in Patients With PiZZ-Emphysema, Candidates for Lung Transplantation.Acute Liver Failure/Injury Related to Drug Reaction With Eosinophilia and Systemic Symptoms: Outcomes and Prognostic Factors.Extended liver resection for polycystic liver disease can challenge liver transplantation.
P50
Q27025448-5EAE1DCE-3186-4C3F-88C6-F42B8355C579Q28365364-49A3303E-B9E4-4797-BB61-7CBF526E2029Q30278436-0AF799F1-85D4-4204-9921-655C57C43BD5Q33425404-DAA026DF-F319-4819-9100-329FD2B88842Q33574176-5C29DD47-8A30-416B-A6D4-CF48D4F076F1Q33731992-259A8FCA-B2C6-4E44-9B3A-13D9BA78E762Q33957581-D699474B-10BB-441D-8E5D-25290C553C44Q33958028-F3F49DD9-58BD-44C3-BB2C-D4EA635FE216Q34177327-2E0E6B5B-8ACE-4B21-BE55-FC06159ACF4FQ34526007-15240E85-C95F-449F-8918-6AFC166D8761Q34584336-8BD8F6F7-A7D1-415C-82E2-AFC1F4C1DDA3Q34794004-5BD7D677-0DE0-494D-84C8-BB90E8E23673Q35597379-8FBD84EE-3AE9-44AD-B992-5D5165589FBEQ35695335-57BE699B-3FAA-410D-BE64-687766A043FEQ35908218-7E4AEF8C-34BB-4B31-A444-23E14C00B74EQ36074799-4CE3187D-8F19-4D29-B96A-28C14D49F7ABQ36299271-A974192B-648A-4A01-9253-1E6074AFEFB3Q36726179-208FD487-A3D6-4D14-AE46-8E83C590824AQ37058087-7F7CE113-450D-4723-BF7F-35E736287B3EQ37091946-5E9EA06D-784F-43D5-8116-9DC17BDBEB74Q37204576-EDFE928F-9922-4DDE-9494-C01DFE1529F8Q37217853-891D5A61-6597-4841-A2DA-BA411F97DAABQ37331902-E5288EDB-5090-425C-9A06-EABBF960DC24Q37626629-B86098A1-5187-4C52-A9D1-C41AF97646E0Q37698770-88A5CC3D-EFBD-4545-8EDF-6CC664014417Q37784560-8E80D8A6-D596-44D4-8554-E52189AC4A8EQ37899841-365C521B-4441-4E08-B67F-F09987C34122Q37980894-D87A92A7-A98F-477A-B135-660D99B13E2FQ38336120-534C02A1-B947-47E2-965B-6ABDD1FEE2E4Q38452484-EDB19D0A-F644-4D4E-9E8D-B7BAC810C8A0Q38593649-629AC5B5-F383-45B9-BC6C-BE8AA58EEDD6Q38616211-DDBD4CBE-CC16-496E-9CFF-988023984D8CQ38774864-82E80E8B-B5BD-404A-8A1D-532F7B5B0F51Q38809496-2D588CA5-A739-4935-8B37-A0452E9257B8Q38847856-C7A65BB8-0769-4FF2-9D89-1FADF447E035Q38898820-C849BA9A-2C90-4EAE-B5C3-6636E2B49CE2Q39082532-798D2BFE-5482-41F3-AFBE-6E5C998A42EBQ39119369-8DD546F5-1E6E-4056-8F98-49F36BC1A48DQ39138958-28D9D23B-10C1-4DB3-B31E-0A5A21416AE8Q39277652-546711CD-55E5-4D28-ACDC-96FBC0566F25
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Francois Durand
@ast
Francois Durand
@en
Francois Durand
@es
Francois Durand
@nl
Francois Durand
@sl
type
label
Francois Durand
@ast
Francois Durand
@en
Francois Durand
@es
Francois Durand
@nl
Francois Durand
@sl
prefLabel
Francois Durand
@ast
Francois Durand
@en
Francois Durand
@es
Francois Durand
@nl
Francois Durand
@sl
P214
P106
P1153
55631285500
P214
P31
P496
0000-0002-0357-1090
P735
P7859
viaf-200012806